Dicer-DX: the first liquid biopsy for early detection and monitoring of DICER1 syndrome pediatric cancers

Ended Project Grant Awarded Last action

Award ID
R44CA228850
Recipient
Awarding agency
Obligated
$1,497,070

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
Virginia, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $747,004
Amendment $0
Amendment $183
Original award $749,883

Quick answers

Who received award R44CA228850?

R44CA228850 was awarded to Resourcepath, LLC by National Cancer Institute (National Institutes of Health) on May 7, 2018.

How much is award R44CA228850 worth?

$1,497,070 has been obligated on R44CA228850.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award